JPRN-UMIN000036012招募中2 期
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer - cytoreductive radical prostatectomy combined with best systemic therapy in men with metastatic prostate cancer (SIMCAP)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 190
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1Males under the age of 18. 2 Refuses to give informed consent. 3Deemed to have unresectable disease by surgeon. 4Received ADT for more than 6 months prior to randomization. 5Life expectancy of less than 6 months. 6 Known spinal cord compression. 7M1c disease (solid organ metastasis). 8 DVT/PE in the past 6 months. 9Previous local therapy for prostate cancer.
研究者
相似试验
招募中
不适用
The impact of prostatectomy combined with systemic therapy in men with metastatic prostate cancerKCT0004129ational Cancer Center30
进行中（未招募）
2 期
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate CancerStage IV Prostate Adenocarcinoma AJCC v7NCT03456843Yale University190
进行中（未招募）
1 期
Response evaluation with 68Ga-PSMA PET of metastatic prostate cancer castration resistant patients in treatment with 223RaCl2Patients mCRPC eligible to treatment with 223RaCl2MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10005993Term: Bone metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10036223Term: Positron emission tomographySystem Organ Class: 100000004848MedDRA version: 21.1Level: PTClassification code 10062904Term: Hormone-refractory prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001395-38-ITAZIENDA USL DELLA VALLE D'AOSTA50
招募中
不适用
Comparing two techniques of surgical treatment for advanced prostate cancerCTRI/2016/06/006986Institutional Internal Fluid Research Funding70
进行中（未招募）
1 期
Prostate spesific membrane antigen single photon emission computed tomography in staging of prostate cancer: a randomised trialProstate cancerEUCTR2021-000486-33-FITurku University Hospital320